Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000–2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 1×
“Although only risperidone and aripiprazole (both atypical antipsychotics) have been approved by the Food and Drug Administration for treatment of aggression and irritability in ASD, many medications are commonly prescribed (Ching and Pringshei, 2012; McCracken et al., 2002; Posey et al., 2008).”
BackgroundPrevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007
Kogan, M. D., Blumberg, S. J., Schieve, L. A., Boyle, C. A., Perrin, J. M., Ghandour, R. M., Singh, G. K., Strickland, B. B., Trevathan, E., & van Dyck, P. C. (2009) · Pediatrics · doi:10.1542/peds.2009-1522 · Cited by 892
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders
Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008) · Pediatrics · doi:10.1542/peds.2007-0984 · Cited by 295
Use of clonidine in children with autism spectrum disorders
Ming, X., Gordon, E., Kang, N., & Wagner, G. C. (2008) · Brain and Development · doi:10.1016/j.braindev.2007.12.007 · Cited by 183 · cited 1×
“For example, clonidine and guanfacine, both alpha(2)-agonists originally developed for the treatment of hypertension (Scahill, 2009), are now FDA approved for treatment of ADHD in children and adolescents (Ming et al., 2008; Wilens et al., 2012).”
BackgroundAlpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness
Scahill, L. (2009) · CNS Drugs · doi:10.2165/00023210-200923000-00006 · Cited by 58
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Aggression in autism spectrum disorder: presentation and treatment options
Fitzpatrick, S., Srivorakiat, L., Wink, L., Pedapati, E., & Erickson, C. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84585 · Cited by 271
Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review
Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12644 · Cited by 263
Houghton, R., Ong, R. C., & Bolognani, F. (2017) · Autism Research · doi:10.1002/aur.1848 · Cited by 124
Gordon, I., Jack, A., Pretzsch, C. M., Vander Wyk, B., Leckman, J. F., Feldman, R., & Pelphrey, K. A. (2016) · Scientific Reports · doi:10.1038/srep35054 · Cited by 114
Metadata
- Authors
- Schubart, J. R., Camacho, F., & Leslie, D.
- Venue
- Autism
- Publisher
- SAGE Publications
- Published
- 2013-10-28
- Volume
- 18
- Issue
- 6
- Pages
- 631-637
- ISSN
- 1362-3613 (ISSN-L)
- 1461-7005
- OpenAlex
- W2125063955
- Cited by
- 80
- References
- 5
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. https://app.cochat.ai/papers/10.1177/1362361313497537
- The paper
- Schubart, J. R., Camacho, F., & Leslie, D. (2014). Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. Autism. https://doi.org/10.1177/1362361313497537
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.